West Pharmaceutical [WST] vs Intuitive Surgical [ISRG] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: West Pharmaceutical Services Inc. wins in 11 metrics, Intuitive Surgical, Inc. wins in 9 metrics, with 0 ties. West Pharmaceutical Services Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric West Pharmaceutical Services Inc. Intuitive Surgical, Inc. Better
P/E Ratio (TTM) 40.99 54.97 West Pharmaceutical Services Inc.
Price-to-Book Ratio 6.94 8.99 West Pharmaceutical Services Inc.
Debt-to-Equity Ratio 10.73 0.95 Intuitive Surgical, Inc.
PEG Ratio 0.74 3.30 West Pharmaceutical Services Inc.
EV/EBITDA 24.63 43.46 West Pharmaceutical Services Inc.
Profit Margin (TTM) 16.85% 28.38% Intuitive Surgical, Inc.
Operating Margin (TTM) 21.70% 30.16% Intuitive Surgical, Inc.
EBITDA Margin (TTM) 21.70% 30.16% Intuitive Surgical, Inc.
Return on Equity 19.13% 16.69% West Pharmaceutical Services Inc.
Return on Assets (TTM) 11.21% 9.39% West Pharmaceutical Services Inc.
Free Cash Flow (TTM) $468.90M $2.49B Intuitive Surgical, Inc.
Dividend Yield 0.46% N/A N/A
1-Year Return 48.18% -19.74% West Pharmaceutical Services Inc.
Price-to-Sales Ratio (TTM) 6.72 15.93 West Pharmaceutical Services Inc.
Enterprise Value $21.43B $154.62B Intuitive Surgical, Inc.
EV/Revenue Ratio 6.65 15.36 West Pharmaceutical Services Inc.
Gross Profit Margin (TTM) 35.08% 66.44% Intuitive Surgical, Inc.
Revenue per Share (TTM) $45 $28 West Pharmaceutical Services Inc.
Earnings per Share (Diluted) $7.47 $8.21 Intuitive Surgical, Inc.
Beta (Stock Volatility) 1.15 1.68 West Pharmaceutical Services Inc.
Short % of Float 4.38% 1.91% Intuitive Surgical, Inc.

West Pharmaceutical Services Inc. vs Intuitive Surgical, Inc. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
West Pharmaceutical Services Inc.0.79%3.65%9.42%37.92%21.91%19.91%
Intuitive Surgical, Inc.1.34%-0.49%-1.09%-13.84%-25.55%-25.88%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
West Pharmaceutical Services Inc.48.18%-9.18%-6.66%345.01%1,441.58%1,794.12%
Intuitive Surgical, Inc.-19.74%24.81%40.32%476.52%974.11%3,431.44%

Performance & Financial Health Analysis: West Pharmaceutical Services Inc. vs Intuitive Surgical, Inc.

MetricWSTISRG
Market Information
Market Cap i$22.07B$170.06B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,085,8302,113,347
90 Day Avg. Volume i930,3271,799,766
Last Close$331.43$416.55
52 Week Range$206.80 - $336.82$396.68 - $603.88
% from 52W High-1.60%-31.02%
All-Time High$475.35 (Sep 06, 2021)$616.00 (Jan 20, 2025)
% from All-Time High-30.28%-32.38%
Growth Metrics
Quarterly Revenue Growth0.21%0.19%
Quarterly Earnings Growth0.55%0.16%
Financial Health
Profit Margin (TTM) i0.17%0.28%
Operating Margin (TTM) i0.22%0.30%
Return on Equity (TTM) i0.19%0.17%
Debt to Equity (MRQ) i10.730.95
Cash & Liquidity
Book Value per Share (MRQ)$44.11$50.19
Cash per Share (MRQ)$7.38$16.71
Operating Cash Flow (TTM) i$715.30M$3.03B
Levered Free Cash Flow (TTM) i$275.66M$2.27B
Dividends
Last 12-Month Dividend Yield i0.46%N/A
Last 12-Month Dividend i$1.07N/A

Valuation & Enterprise Metrics Analysis: West Pharmaceutical Services Inc. vs Intuitive Surgical, Inc.

MetricWST (Apr 26, 2026)ISRG (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i40.9954.97
Forward P/E i32.0539.49
PEG Ratio i0.743.30
Price to Sales (TTM) i6.7215.93
Price to Book (MRQ) i6.948.99
Market Capitalization
Market Capitalization i$22.07B$170.06B
Enterprise Value i$21.43B$154.62B
Enterprise Value Metrics
Enterprise to Revenue i6.6515.36
Enterprise to EBITDA i24.6343.46
Risk & Other Metrics
Beta i1.151.68
Book Value per Share (MRQ) i$44.11$50.19

Financial Statements Comparison: West Pharmaceutical Services Inc. vs Intuitive Surgical, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricWST (2025)ISRG (2025)
Revenue/Sales i3.07B10.06B
Cost of Goods Sold i1.97B3.42B
COGS % of Revenue i64.1%34.0%
Gross Profit i1.10B6.64B
Gross Margin i35.9%66.0%
Research & Development i74.30M1.31B
Operating Income (EBIT) i636.10M2.95B
Operating Margin i20.7%29.3%
EBITDA i822.70M3.62B
EBITDA Margin i26.8%36.0%
Pre-Tax Income i600.90M3.31B
Pre-Tax Income % of Revenue i19.5%32.9%
Income Tax i121.60M434.80M
Income Tax % of Revenue i4.0%4.3%
Net Income (Profit) i493.70M2.88B
Profit Margin i16.1%28.6%

Balance Sheet & Liquidity Metrics

MetricWST (2025)ISRG (2025)
Cash & Equivalents i791.30M3.37B
Total Current Assets i1.98B9.78B
Total Current Assets % of Revenue i64.4%97.2%
Total Current Liabilities i654.90M2.01B
Total Current Liabilities % of Revenue i21.3%19.9%
Long-Term Debt i298.40MN/A
Long-Term Debt % of Revenue i9.7%0.0%
Total Shareholders Equity i3.18B17.94B
Retained Earnings i4.37B7.01B
Retained Earnings % of Revenue i142.3%69.7%
Property, Plant & Equipment i296.40M2.10B

Cash Flow Statement Comparison

MetricWST (2025)ISRG (2025)
Operating Cash Flow i753.00M3.28B
Operating Cash Flow % of Revenue i24.5%32.5%
Capital Expenditures iN/A-539.80M
Free Cash Flow i468.90M2.49B
FCF Margin i15.3%24.7%
Debt Repayment i-1.10MN/A
Common Stock Repurchase i-136.80M-2.30B

Short Interest & Institutional Ownership Analysis

MetricWSTISRG
Shares Short i2.66M6.75M
Short Ratio i3.184.19
Short % of Float i4.38%1.91%
Shares Outstanding i70.90M355.10M
Float Shares i70.15M352.94M
% Held by Insiders i0.64%0.56%
% Held by Institutions i99.21%89.20%
% Held by Public i0.15%10.24%

Dividend Analysis & Yield Comparison: West Pharmaceutical Services Inc. vs Intuitive Surgical, Inc.

MetricWSTISRG
Last 12-Month Dividend i$1.07N/A
Last 12-Month Dividend Yield i0.46%N/A
3-Year Avg Annual Dividend i$0.82N/A
3-Year Avg Dividend Yield i0.07%N/A
3-Year Total Dividends i$2.46N/A
Ex-Dividend DateJan 28, 2026N/A